Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial

被引：0
|
作者：
Yamanaka, R [1 ]
Homma, J [1 ]
Yajima, N [1 ]
Tsuchiya, N [1 ]
Tanaka, R [1 ]
机构：
[1] Niigata Univ, Brain Res Inst, Niigata, Japan
来源：
MOLECULAR THERAPY | 2004年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
254
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [41] Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
    Trepiakas, Redas
    Berntsen, Annika
    Hadrup, Sine Reker
    Bjorn, Jon
    Geertsen, Poul F.
    Straten, Per Thor
    Andersen, Mads H.
    Pedersen, Anders E.
    Soleimani, Amir
    Lorentzen, Torben
    Johansen, Julia S.
    Svane, Inge Marie
    CYTOTHERAPY, 2010, 12 (06) : 721 - 734
  • [42] Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
    Juan Hernando
    Tjoung-Won Park
    Kirsten Kübler
    Ruth Offergeld
    Harald Schlebusch
    Thomas Bauknecht
    Cancer Immunology, Immunotherapy, 2002, 51 : 45 - 52
  • [43] Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies:: clinical and immunological evaluation of a phase I trial
    Hernando, JJ
    Park, TW
    Kübler, K
    Offergeld, R
    Schlebusch, H
    Bauknecht, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (01) : 45 - 52
  • [44] Immunological and clinical response after vaccination therapy of pancreatic carcinoma patients with autologous, tumor-lysate pulsed dendritic cells: Results of a phase II-study
    Bauer, C.
    Dauer, M.
    Saraj, S.
    Schnurr, M.
    Jauch, K.
    Ruettinger, D.
    Bruns, C.
    Emmerich, B.
    Endres, S.
    Eigler, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Vaccination of Japanese patients with advanced melanoma with peptide, tumor lysate or both peptide and tumor lysate-pulsed mature, monocyte-derived dendritic cells
    Nakai, Noriaki
    Asai, Jun
    Ueda, Eiichiro
    Takenaka, Hideya
    Katoh, Norito
    Kishimoto, Saburo
    JOURNAL OF DERMATOLOGY, 2006, 33 (07): : 462 - 472
  • [46] A Phase I/II Trial of Combination Therapy of Tumor Lysate-pulsed Dendritic Cells and Adoptive Transfer of Anti-CD3 Activated T Cells (ATVAC) in Patients With Advanced Gastrointestinal (GI) Cancers
    Shimizu, Koichi
    Tanigawa, Keishi
    Takeshita, Nobuhiro
    Fujisawa, Toshimi
    Takasaki, Ken
    Yamamoto, Masakazu
    Aruga, Atsuhi
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 926 - 926
  • [47] A phase I clinical trial in patients with newly diagnosed glioblastoma vaccinated with autologous dendritic cells pulsed with autologous tumor lysate.
    Boynton, A. L.
    Prins, R.
    Bosch, M.
    Yang, M.
    Odesa, S. K.
    Khan-Farooqi, H.
    Cloughesy, T.
    Liau, L.
    CYTOTHERAPY, 2006, 8
  • [48] Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
    Geiger, JD
    Hutchinson, RJ
    Hohenkirk, LF
    McKenna, EA
    Yanik, GA
    Levine, JE
    Chang, AE
    Braun, TM
    Mulé, JJ
    CANCER RESEARCH, 2001, 61 (23) : 8513 - 8519
  • [49] Phase I/II trial of dendritic cells pulsed with telomerase.
    Marten, A
    Sievers, E
    Albers, P
    Muller, S
    Franchy, C
    von Rucker, A
    Strunk, H
    Schild, HH
    Sauerbruch, T
    Schmidt-Wolf, IGH
    BLOOD, 2004, 104 (11) : 380A - 380A
  • [50] Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
    Lau, S. P.
    Klaase, L.
    Vink, M.
    Dumas, J.
    Bezemer, K.
    van Krimpen, A.
    van der Breggen, R.
    Wismans, L. V.
    Doukas, M.
    de Koning, W.
    Stubbs, A. P.
    Mustafa, D. A. M.
    Vroman, H.
    Stadhouders, R.
    Nunes, J. B.
    Stingl, C.
    de Miranda, N. F. C. C.
    Luider, T. M.
    Burg, S. H. van der
    Aerts, J. G.
    van Eijck, C. H. J.
    EUROPEAN JOURNAL OF CANCER, 2022, 169 : 20 - 31
12345